Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Q32 Bio (QTTB) EBT (2018 - 2025)

Historic EBT for Q32 Bio (QTTB) over the last 8 years, with Q3 2025 value amounting to -$7.4 million.

  • Q32 Bio's EBT rose 5800.51% to -$7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.1 million, marking a year-over-year increase of 2835.88%. This contributed to the annual value of -$46.1 million for FY2024, which is 1373.51% up from last year.
  • Q32 Bio's EBT amounted to -$7.4 million in Q3 2025, which was up 5800.51% from -$9.5 million recorded in Q2 2025.
  • In the past 5 years, Q32 Bio's EBT registered a high of $93.7 million during Q1 2022, and its lowest value of -$33.6 million during Q4 2021.
  • For the 5-year period, Q32 Bio's EBT averaged around -$11.7 million, with its median value being -$14.2 million (2024).
  • Per our database at Business Quant, Q32 Bio's EBT surged by 882907.74% in 2022 and then crashed by 101543.57% in 2025.
  • Q32 Bio's EBT (Quarter) stood at -$33.6 million in 2021, then grew by 1.62% to -$33.0 million in 2022, then grew by 18.84% to -$26.8 million in 2023, then surged by 47.16% to -$14.2 million in 2024, then surged by 47.85% to -$7.4 million in 2025.
  • Its last three reported values are -$7.4 million in Q3 2025, -$9.5 million for Q2 2025, and -$11.0 million during Q1 2025.